Amgen (AMGN) Free Cash Flow (2009 - 2026)

Amgen's Free Cash Flow history runs 18 years deep, the most recent figure standing at $1.5 billion for Q1 2026.

• In Q1 2026, Free Cash Flow rose 50.71% year-over-year to $1.5 billion; the TTM figure through Mar 2026 stood at $8.6 billion (down 21.24% YoY), while the FY2025 annual figure was $8.1 billion, down 22.07% from the prior year.
• Free Cash Flow was $1.5 billion for Q1 2026 at Amgen, up from $961.0 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $4.4 billion in Q4 2024 to a low of $289.0 million in Q4 2023.
• Historically, Free Cash Flow has averaged $2.1 billion across 5 years, with a median of $2.0 billion in 2022.
• The sharpest annual moves came in 2023 and 2024: Free Cash Flow tumbled 87.48% in 2023, then jumped 1422.49% in 2024.
• A 5-year view of Free Cash Flow shows it stood at $2.3 billion in 2022, then sank by 87.48% to $289.0 million in 2023, then surged by 1422.49% to $4.4 billion in 2024, then slumped by 78.16% to $961.0 million in 2025, then soared by 53.69% to $1.5 billion in 2026.
• The last three Free Cash Flow figures came in at $1.5 billion (Q1 2026), $961.0 million (Q4 2025), and $4.2 billion (Q3 2025), per Business Quant data.